Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,884,263
-$2,824,334 QoQ
Shares Held
19,011
-31.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#684
of 3,140 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITAL INTERNATIONAL LTD /CA/ holds $216,358,127 across 7 Drug Manufacturers - General names. AMGN ranks #5 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
506,085 | $95,963,837 | |
| 2 | LLY |
ELI LILLY & Co
|
71,334 | $85,560,146 | |
| 3 | ABBV |
AbbVie Inc.
|
44,477 | $11,192,192 | |
| 4 | PFE |
Pfizer Inc
|
439,717 | $10,588,385 | |
| 5 | AMGN |
Amgen Inc
This page
|
19,011 | $6,884,263 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
57,368 | $3,305,544 | |
| 7 | GRFS |
Grifols SA
|
404,486 | $2,863,760 |
All Filings in AMGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,884,263 | 19,011 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $9,708,597 | 27,593 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,918,870 | 27,249 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $15,750,428 | 55,813 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,583,473 | 30,742 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $9,577,670 | 30,742 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||